VEGFA and cancer: Findings regarding hsa-miR-21-5p and its interaction with hypoxia-inducible factors HIF1A and HIF2A or its influence on VEGFA signaling highlight its impact on cancer progression and therapeutic implications [59,60,61,62,78,79].